These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39378027)

  • 1. Hydroxyurea and follicle density in sickle cell.
    Creary S; Kebodeaux C; Nahata L
    Blood Adv; 2024 Oct; 8(19):5225-5226. PubMed ID: 39378027
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a Longitudinal Study.
    Elsherif L; Scott LC; Wichlan D; Jones SK; Mathias JG; Shen JH; Smeltzer MP; Ataga KI
    Br J Haematol; 2021 Aug; 194(3):e71-e73. PubMed ID: 34231209
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxyurea for the treatment of sickle cell anemia.
    Platt OS
    N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxyurea and new agents for the treatment of sickle cell disease.
    Rodgers GP
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.
    Lemonne N; Charlot K; Waltz X; Ballas SK; Lamarre Y; Lee K; Hierso R; Connes C; Etienne-Julan M; Romana M; Connes P
    Haematologica; 2015 Oct; 100(10):e383-6. PubMed ID: 26137960
    [No Abstract]   [Full Text] [Related]  

  • 6. Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases.
    Italia KY; Jijina FF; Chandrakala S; Nadkarni AH; Sawant P; Ghosh K; Colah RB
    J Clin Pharmacol; 2010 Feb; 50(2):231-4. PubMed ID: 19797538
    [No Abstract]   [Full Text] [Related]  

  • 7. Social media discussions provide new insight about perceptions of hydroxyurea in the sickle cell community.
    Walker AL; Gaydos LM; Farzan R; De Castro L; Jonassaint C
    Am J Hematol; 2019 May; 94(5):E134-E136. PubMed ID: 30734364
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxyurea does not affect the spermatogonial pool in prepubertal patients with sickle cell disease.
    Gille AS; Pondarré C; Dalle JH; Bernaudin F; Chalas C; Fahd M; Jean C; Lezeau H; Riou L; Drouineaud V; Paye-Jaouen A; Kamdem A; Neven B; Arnaud C; Azarnoush S; Yakouben K; Sarnacki S; de Montalembert M; Comperat EM; Lenaour G; Sibony M; Dhédin N; Vaiman D; Wolf JP; Patrat C; Fouchet P; Poirot C; Barraud-Lange V
    Blood; 2021 Feb; 137(6):856-859. PubMed ID: 33259585
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of hydroxyurea therapy on resting energy expenditure in children with sickle cell disease.
    Fung EB; Barden EM; Kawchak DA; Zemel BS; Ohene-Frempong K; Stallings VA
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):604-8. PubMed ID: 11902305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
    Okam MM; Ebert BL
    Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell solutions in sight.
    Kingwell K
    Nat Rev Drug Discov; 2016 Aug; 15(9):593-594. PubMed ID: 27573222
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
    Covas DT; de Lucena Angulo I; Vianna Bonini Palma P; Zago MA
    Haematologica; 2004 Mar; 89(3):273-80. PubMed ID: 15020264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea marketed for sickle cell anemia.
    Am J Health Syst Pharm; 1998 May; 55(9):875. PubMed ID: 9588244
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of hydroxyurea on adhesion proteins in sickle cell anemia].
    Odièvre MH; Lapouméroulie C; Elion J
    Arch Pediatr; 2009 Feb; 16(2):95-8. PubMed ID: 19167870
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyurea for sickle cell anemia.
    Naina HV; Harris S
    N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18596283
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term use of hydroxyurea for sickle cell anemia.
    Lee DA; Mueller BU
    JAMA; 2003 Aug; 290(6):753-4; author reply 754. PubMed ID: 12915425
    [No Abstract]   [Full Text] [Related]  

  • 17. Exposure to hydroxyurea and pregnancy outcomes in patients with sickle cell anemia.
    Ballas SK; McCarthy WF; Guo N; DeCastro L; Bellevue R; Barton BA; Waclawiw MA;
    J Natl Med Assoc; 2009 Oct; 101(10):1046-51. PubMed ID: 19860305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea, sickle cell disease and renal transplantation.
    Allen A; Scoble J; Snowden S; Hambley H; Bellingham A
    Nephron; 1997; 75(1):106-7. PubMed ID: 9031282
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxyurea for Sickle Cell Disease: Now Is the Time!
    Strouse JJ
    South Med J; 2016 Sep; 109(9):535-7. PubMed ID: 27598356
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.
    Adekile A; Menzel S; Gupta R; Al-Sharida S; Farag A; Haider M; Akbulut N; Mustafa N; Thein SL
    Am J Hematol; 2015 Jul; 90(7):E138-9. PubMed ID: 25851995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.